MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202621063093 A) filed by Mr. Anwar Chaudhari; Dr. Vinod Ugale; Dr. Prasad Kulkarni; Dr. Atul Shirkhedkar; Dr. Sanjay Surana; and Miss. Durgeshwari Kalal on May 19, 2026, for Fused Naphthalene-Chromene Scaffold As Dual Cholinesterase Inhibitors And Applications Thereof.
Inventors include Mr. Anwar Chaudhari; Dr. Vinod Ugale; Dr. Prasad Kulkarni; Dr. Atul Shirkhedkar; Dr. Sanjay Surana; and Miss. Durgeshwari Kalal.
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: ABSTRACT FUSED NAPHTHALENE-CHROMENE SCAFFOLD AS DUAL CHOLINESTERASE INHIBITORS AND APPLICATIONS THEREOF 5 10 The present invention relates to the development of therapeutic agents for the treatment and management of neurological disorders, also, relates to process of preparation of naphthalene-chromene scaffold exhibiting selective inhibitory activity against acetylcholinesterase and/or butyrylcholinesterase. Naphthalene chromene molecules, pharmaceutical compositions comprising the same, and their use as selective anti-cholinesterase agents for the treatment, prevention, or management of neurodegenerative disorders associated with cholinergic dysfunction, especially Alzheimer’s disease.
Disclaimer: Curated by HT Syndication.
